Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1970
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 3
1971 2
1972 1
1973 1
1974 3
1977 3
1978 2
1979 2
1980 3
1981 5
1983 2
1984 10
1985 8
1986 4
1987 8
1988 3
1989 9
1990 3
1991 6
1992 7
1993 15
1994 11
1995 11
1996 16
1997 11
1998 7
1999 9
2000 14
2001 8
2002 8
2003 11
2004 8
2005 8
2006 6
2007 4
2008 11
2009 5
2010 12
2011 7
2012 6
2013 12
2014 9
2015 6
2016 10
2017 12
2018 11
2019 5
2020 8
2021 12
2022 8
2023 5
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

353 results

Results by year

Filters applied: . Clear all
Page 1
Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation.
Lonergan GJ, Schwab CM, Suarez ES, Carlson CL. Lonergan GJ, et al. Radiographics. 2002 Jul-Aug;22(4):911-34. doi: 10.1148/radiographics.22.4.g02jl15911. Radiographics. 2002. PMID: 12110723 Review.
Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma are tumors of the sympathetic nervous system that arise from primitive sympathogonia and are referred to collectively as neuroblastic tumors. ...Despite recent advances in treatment, including bone
Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma are tumors of the sympathetic nervous system that arise from primitive
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
Park JR, Bagatell R, Cohn SL, Pearson AD, Villablanca JG, Berthold F, Burchill S, Boubaker A, McHugh K, Nuchtern JG, London WB, Seibel NL, Lindwasser OW, Maris JM, Brock P, Schleiermacher G, Ladenstein R, Matthay KK, Valteau-Couanet D. Park JR, et al. J Clin Oncol. 2017 Aug 1;35(22):2580-2587. doi: 10.1200/JCO.2016.72.0177. Epub 2017 May 4. J Clin Oncol. 2017. PMID: 28471719 Free PMC article. Review.
Results Overall response in the revised INRC will integrate tumor response in the primary tumor, soft tissue and bone metastases, and bone marrow. ...Bone marrow with 5% tumor involvement will be classified as minimal disease. Urinary cat …
Results Overall response in the revised INRC will integrate tumor response in the primary tumor, soft tissue and bone m …
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, et al. Brodeur GM, et al. J Clin Oncol. 1993 Aug;11(8):1466-77. doi: 10.1200/JCO.1993.11.8.1466. J Clin Oncol. 1993. PMID: 8336186 Review.
Substantial changes included a redefinition of the midline, restrictions on age and bone marrow involvement for stage 4S, and the recommendation that meta-iodobenzylguanidine (MIBG) scanning be implemented for evaluating the extent of disease. ...The biologic features that …
Substantial changes included a redefinition of the midline, restrictions on age and bone marrow involvement for stage 4S, and the rec …
Esthesioneuroblastoma.
Ow TJ, Bell D, Kupferman ME, Demonte F, Hanna EY. Ow TJ, et al. Neurosurg Clin N Am. 2013 Jan;24(1):51-65. doi: 10.1016/j.nec.2012.08.005. Neurosurg Clin N Am. 2013. PMID: 23174357 Review.
The many faces of neuroblastoma.
David R, Lamki N, Fan S, Singleton EB, Eftekhari F, Shirkhoda A, Kumar R, Madewell JE. David R, et al. Radiographics. 1989 Sep;9(5):859-82. doi: 10.1148/radiographics.9.5.2678295. Radiographics. 1989. PMID: 2678295 Review.
Neuroblastoma is a common tumor in childhood. It arises in the adrenal gland or in various extraadrenal primary sites of the sympathetic chain. ...
Neuroblastoma is a common tumor in childhood. It arises in the adrenal gland or in various extraadrenal primary sites of the sympathe …
Naxitamab: First Approval.
Markham A. Markham A. Drugs. 2021 Feb;81(2):291-296. doi: 10.1007/s40265-021-01467-4. Drugs. 2021. PMID: 33616889 Review.
Naxitamab was recently granted accelerated approval by the US FDA for marketing as treatment (in combination with granulocyte-macrophage colony-stimulating factor) for paediatric patients at least one year of age and adult patients with relapsed or refractory high-risk neuroblast …
Naxitamab was recently granted accelerated approval by the US FDA for marketing as treatment (in combination with granulocyte-macrophage col …
Evidence-based practice: endoscopic skull base resection for malignancy.
Rawal RB, Gore MR, Harvey RJ, Zanation AM. Rawal RB, et al. Otolaryngol Clin North Am. 2012 Oct;45(5):1127-42. doi: 10.1016/j.otc.2012.06.013. Otolaryngol Clin North Am. 2012. PMID: 22980689 Review.
Successful outcomes of endoscopic approaches to benign sinonasal tumors have launched interest in expanding its use for sinonasal malignancy. Because of the heterogeneity and rarity of sinonasal malignancy, evidence for clinical outcomes of endoscopic approaches versus tra …
Successful outcomes of endoscopic approaches to benign sinonasal tumors have launched interest in expanding its use for sinonasal mal …
Spinal Canal Involvement in Neuroblastoma.
Trahair T, Sorrentino S, Russell SJ, Sampaio H, Selek L, Plantaz D, Freycon C, Simon T, Kraal K, Beck-Popovic M, Haupt R, Ash S, De Bernardi B. Trahair T, et al. J Pediatr. 2017 Sep;188:294-298. doi: 10.1016/j.jpeds.2017.05.051. Epub 2017 Jun 20. J Pediatr. 2017. PMID: 28645442 Review. No abstract available.
353 results